Novo Nordisk is currently running two large Phase 3 trials to investigate the effect of GLP-1 drugs on Alzheimer's disease, based on early data suggesting reduced neuroinflammation, improved cognition and function, and enhanced memory, as well as trials in which GLP-1 drugs appeared to substantially reduce dementia rates in diabetes patients
Beyond its primary function of lowering blood sugar, significant clinical trials have demonstrated that Semaglutide offers additional health benefits
In G2019S LRRK2 knock-in mice, LPS-induced inflammation leads to increased iron accumulation and enhanced ferritin staining in microglia (194)
Keys, A., Broek, J., Henschel, A., Mickelsen, O
Ozempic, Semaglutide and tirzepatide are prescribed based on individual health profiles and are subject to contraindications, dosing protocols, and monitoring requirements
Tips for Responsible Alcohol Consumption: For those choosing to incorporate alcohol while on GLP-1 medications, responsible consumption is crucial
